Schwartz's Quantas hopes may fade

The report said 2,500 pilots each were planning to invest $39,000, giving them 1% of the company, to block the sale on concerns that the new owners would cuts jobs and sell assets.

By AVI KRAWITZ
December 19, 2006 07:40

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Pilots at Quantas Airways are attempting to block the Australian airline's $8.8 billion buyout by Onex Corporation, controlled by Canadian businessman and renowned supporter of Israel Gerry Schwartz, and private equity group Airline Partners Australia, The Austrian newspaper reported Monday. The report said 2,500 pilots each were planning to invest $39,000, giving them 1% of the company, to block the sale on concerns that the new owners would cuts jobs and sell assets. The move would only be contemplated if the pilots knew they could recruit more than 10% of shareholders to reject the deal. Onex holds a 50% stake in the consortium that won the privatization tender Thursday.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS